These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11503841)

  • 1. Management of type 2 diabetes: long-awaited evidence of benefits after blood sugar control.
    Prescrire Int; 1999 Oct; 8(43):147-52. PubMed ID: 11503841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.
    Niazi R; Muzaffar Z
    J Pak Med Assoc; 1998 Nov; 48(11):336-8. PubMed ID: 10323055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
    Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycaemic therapy in type 2 diabetes. Part I. Metformin is the only glucose-lowering drug known to prevent complications of diabetes.
    Prescrire Int; 2015 Apr; 24(159):103-6. PubMed ID: 25941708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving survival with metformin: the evidence base today.
    Scarpello JH
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S36-43. PubMed ID: 14502099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.
    Prescrire Int; 2003 Feb; 12(63):28-30. PubMed ID: 12602406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular effects of oral hypoglycemie drugs].
    Herrmann BL; Erbel R; Janssen OE; Mann K
    Herz; 2004 Aug; 29(5):510-8. PubMed ID: 15340737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current role of metformin in treatment of diabetes mellitus type 2].
    Janssen JA
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1900-2. PubMed ID: 11045135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
    Scheen AJ; Paquot N; Lefebvre PJ
    Rev Med Liege; 2008 Oct; 63(10):624-9. PubMed ID: 19009971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin as first choice in oral diabetes treatment: the UKPDS experience.
    Holman R
    Journ Annu Diabetol Hotel Dieu; 2007; ():13-20. PubMed ID: 18613325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.